Systemically Administered Anti-uPAR Antibody Plasma and Lung ELF Pharmacokinetics Characterized by Minimal Lung PBPK Model.
AAPS PharmSciTech
; 24(8): 236, 2023 Nov 21.
Article
in En
| MEDLINE
| ID: mdl-37989972
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Urokinase Plasminogen Activator
/
Lung
Limits:
Animals
Language:
En
Journal:
AAPS PharmSciTech
Journal subject:
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: